Granules India has reported results for third quarter ended December 31, 2019.
The company has reported over 2-fold jump in its net profit at Rs 88.47 crore for the quarter under review as compared to Rs 40.09 crore for the same quarter in the previous year. Total income of the company increased by 5.72% at Rs 620.18 crore for Q3FY20 as compared Rs 586.65 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 6.15% in its net profit at Rs 64.03 crore for the quarter under review as compared to Rs 60.32 crore for the same quarter in the previous year. Total income of the company increased by 10.95% at Rs 707.47 crore for Q3FY20 as compared Rs 637.65 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1483.75 |
Dr. Reddys Lab | 5947.30 |
Cipla | 1347.70 |
Zydus Lifesciences | 958.90 |
Lupin | 1580.00 |
View more.. |